Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Fumarate and Hydrocodone and Chlorpheniramine Extended-Release Suspension

• Generic Name: cobicistat / darunavir / emtricitabine / tenofovir alafenamide
• Dosage Forms: n.a.
• Other Brand Names: Symtuza

Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide fumarate is a four-drug combination of darunavir (DRV), an HIV-1 protease inhibitor, cobicistat (COBI), a CYP3A inhibitor, and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 NRTIs, and is indicated as a complete regimen for the treatment of HIV-1 infection in adults who have no prior antiretroviral treatment history or who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen for at least 6 months and have no known substitutions associated with resistance to darunavir or tenofovir.

• Generic Name: chlorpheniramine / hydrocodone
• Dosage Forms: n.a.
• Other Brand Names: TussiCaps, Tussionex PennKinetic, S-T Forte 2, HyTan, Novasus, Vituz

• The use of hydrocodone in children younger than 6 years has led to deadly breathing problems. Talk with the doctor.
• This medicine is not for use in children younger than 18 years of age. The benefits of taking hydrocodone and chlorpheniramine extended-release suspension for a cough due to allergies, a cold, or other infection do not outweigh the risks in children. If your child has been given hydrocodone and chlorpheniramine extended-release suspension or if you have any questions, talk with your child's doctor.